My Eyes, My Light — community eye screening in Char Fasson
Official title: Stop Blindness in Coastal Bangladesh: Testing the Effectiveness of Community-Based, Artificial Intelligence-Assisted Eye Disease Screening in Coastal Bangladesh
Run by Data Yakka, Inc. · NCT07135570 · Data updated 2026-11-12
This project tests whether a community-based screening program can find treatable eye problems in people aged 35 and older who live in Char Fasson, Bangladesh.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 35 Years and up |
| Sex | All |
| Enrollment | 20000 (estimated) |
| Sponsor | Data Yakka, Inc. Industry-sponsored |
| Locations | 1 site (Char Fasson, Bhola) |
| Status | Recruiting |
| Started | January 5, 2025 |
| Main results expected | December 2025 |
| Study ends | June 2026 |
| Registry record updated | August 22, 2025 |
| Trial ID | NCT07135570 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 35 years and older who reside in the Char Fasson sub-district and do not already have a diagnosed eye disease.
✕Probably not a fit
People with a prior diagnosis of eye disease or those living outside Char Fasson who cannot access local screening or follow-up care may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The program conducts multimodal eye screenings for adults aged 35+ in the Char Fasson sub-district using clinical exams, imaging, and AI-assisted tools to detect cataract, glaucoma, diabetic and hypertensive retinopathy, and age-related macular degeneration. Screenings are delivered through outreach to island and rural communities leveraging local Cyclone Preparedness Program volunteers and clinic sites, with referrals to a partnering eye hospital for further evaluation and cataract surgery if indicated. The project is run by Data Yakka in collaboration with local health partners and collects screening data to identify previously undiagnosed eye disease. People with a known eye disease diagnosis are excluded so the effort focuses on detecting new, untreated conditions.
Why it matters
Potential benefit: If successful, it could help people get diagnosed earlier and receive cataract surgery or other care, reducing preventable vision loss in the community.
How similar studies have gone: Previous community screening programs and emerging AI-assisted eye screening tools have increased detection and referral for treatable eye conditions, though outcomes vary with local health system capacity.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 35+ years * Residing in the Sub-District of Char Fasson in the Bhola District Exclusion Criteria: * Known eye disease diagnosis
Where it's running
-
Shashibhushan Clinic
Char Fasson, Bhola, Bangladesh Recruiting
Study contacts
- Principal investigator: Randall Scott Stafford, MD, PhD, MHS — Data Yakka, Inc.
- Study coordinator: Mohammad Saidur Rahman, PhD
- Email: Saidur1943@gmail.com
- Phone: +880 1711-524722
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Auricular Acupressure to Help Prevent Myopia in Young Kids With Limited Hyperopic Reserve
This trial tests whether auricular acupressure, added to standard eye health education, can help prevent myopia in elementary students who don’t have enough hyperopic reserve.
-
Outdoor activity program with wearable support to help prevent myopia in schoolchildren with good hyperopic reserve
A school-based program using a wearable device to promote outdoor activity is tested to see if it can help prevent myopia in kids in grades 1–4 who have adequate hyperopic reserve.
-
Measuring eye pressure and fluid outflow during cataract or glaucoma surgery
This will test whether measuring eye pressure and fluid outflow during cataract or glaucoma surgery with a disposable sensor can help predict and improve recovery for adults having these operations.
-
Bimatoprost implant with SpyGlass intraocular lens vs timolol drops for cataract patients with glaucoma
This study tests whether placing a bimatoprost implant together with a SpyGlass intraocular lens during cataract surgery controls eye pressure better than daily timolol drops in people with mild to moderate open‑angle glaucoma or ocular hypertension.
-
Combining a bimatoprost eye implant with the SpyGlass intraocular lens versus timolol eye drops for people having cataract removal
This study will test whether placing a small bimatoprost implant with the SpyGlass intraocular lens at the time of cataract surgery better controls eye pressure than using timolol eye drops in people with mild to moderate open-angle glaucoma or ocular hypertension.
-
Vision screening in general practice to catch preventable sight loss in people over 70
This project will test a GP-based vision-screening program for people aged 70 and older with at least one chronic condition to find sight problems early.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.